Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  ABIOMED, Inc.    ABMD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Abiomed : invests in Israeli medical device maker Magenta

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/28/2017 | 01:06pm CEST

Israeli medical device company Magenta Medical said on Thursday it has raised $15 million in funding led by Massachusetts-based Abiomed Inc (>> ABIOMED, Inc.), a maker of catheter-based heart pumps, and venture capital firm Pitango.

Israeli medical device company Magenta Medical said on Thursday it has raised $15 million in funding led by Massachusetts-based Abiomed Inc (>> ABIOMED, Inc.), a maker of catheter-based heart pumps, and venture capital firm Pitango.

Japanese venture capital group JAFCO and a group of cardiovascular experts also invested in the round.

The Israeli startup is developing an apparatus for treating acute heart failure which it says can alleviate congestion faster and more safely than diuretics alone. Heart failure afflicts approximately 6.5 million people in the United States alone.

Ehud Schwammenthal, Magenta's co-founder and chief medical officer, said the company's first product was in clinical trials in Europe. The funding, he said, will allow the firm to expand the clinical programme, with the goal of getting approval in Europe and a second study going in the United States.

(Reporting by Dan Pleck; Editing by Tova Cohen)

Stocks treated in this article : ABIOMED, Inc., Medtronic PLC
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ABIOMED, INC.
10/20 ABIOMED : s Impella Technology that Enables Heart Recovery Showcased at TCT 2017..
10/19 Abiomed's Impella® Technology that Enables Heart Recovery Showcased at TCT 20..
10/10 ABIOMED : Second Quarter Fiscal 2018 Earnings and Conference Call Notification
10/09 ABIOMED : 65-- CATH LAB BPA-ABIOMED-Impella Catheters
09/28 ABIOMED : invests in Israeli medical device maker Magenta
09/21 ABIOMED, INC. (NASDAQ : ABMD) Files An 8-K Financial Statements and Exhibits
09/21 ABIOMED INC : Other Events, Financial Statements and Exhibits (form 8-K)
09/21 ABIOMED : Receives FDA PMA Approval for Impella RP® for Right Heart Failure
09/20 Abiomed Receives FDA PMA Approval for Impella RP® for Right Heart Failure
09/12 ABIOMED INC : Entry into a Material Definitive Agreement (form 8-K)
More news
News from SeekingAlpha
10/16 Premarket analyst action - healthcare
10/06 STOCK EXCHANGE : 3,811 U.S. Stocks, How Do You Pick Yours?
10/02 Right Time To Buy Medtronic? Know Why The Company Cannot Go Wrong In Cardiac ..
10/02 YOUR DAILY PHARMA SCOOP : Alexion's Canada Pricing, Zogenix, RedHill, Flexion
09/29 BIOTECH FORUM DAILY DIGEST : Momentum Building For Heron Therapeutics?
Financials ($)
Sales 2018 574 M
EBIT 2018 138 M
Net income 2018 104 M
Finance 2018 316 M
Yield 2018 -
P/E ratio 2018 81,69
P/E ratio 2019 67,34
EV / Sales 2018 12,9x
EV / Sales 2019 9,93x
Capitalization 7 701 M
Chart ABIOMED, INC.
Duration : Period :
ABIOMED, Inc. Technical Analysis Chart | ABMD | US0036541003 | 4-Traders
Technical analysis trends ABIOMED, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 173 $
Spread / Average Target -0,74%
EPS Revisions
Managers
NameTitle
Michael R. Minogue Chairman, President & Chief Executive Officer
David M. Weber Chief Operating Officer
Ian McLeod Controller, Chief Financial & Accounting Officer
Thorsten Siess Chief Technology Officer
Seth Bilazarian Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ABIOMED, INC.53.49%7 701
THERMO FISHER SCIENTIFIC INC.34.10%77 329
DANAHER16.64%63 154
INTUITIVE SURGICAL67.64%41 191
BOSTON SCIENTIFIC CORPORATION36.48%40 738
ROYAL PHILIPS20.29%39 253